Nyxoah (NYXH) Competitors $7.25 -0.21 (-2.82%) Closing price 03:59 PM EasternExtended Trading$7.37 +0.12 (+1.66%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. PLSE, MDXG, INMD, KMTS, SIBN, IRMD, EMBC, BBNX, AXGN, and AVNSShould you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Pulse Biosciences (PLSE), MiMedx Group (MDXG), InMode (INMD), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), Embecta (EMBC), Beta Bionics (BBNX), AxoGen (AXGN), and Avanos Medical (AVNS). These companies are all part of the "medical equipment" industry. Nyxoah vs. Its Competitors Pulse Biosciences MiMedx Group InMode Kestra Medical Technologies SiBone iRadimed Embecta Beta Bionics AxoGen Avanos Medical Nyxoah (NASDAQ:NYXH) and Pulse Biosciences (NASDAQ:PLSE) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation. Which has higher earnings & valuation, NYXH or PLSE? Pulse Biosciences has lower revenue, but higher earnings than Nyxoah. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$4.89M50.50-$64.10M-$2.13-3.40Pulse Biosciences$700K1,474.17-$53.58MN/AN/A Is NYXH or PLSE more profitable? Pulse Biosciences has a net margin of 0.00% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-1,571.39% -63.37% -46.67% Pulse Biosciences N/A -68.44%-58.17% Do analysts rate NYXH or PLSE? Nyxoah currently has a consensus target price of $14.50, indicating a potential upside of 100.00%. Pulse Biosciences has a consensus target price of $22.00, indicating a potential upside of 43.42%. Given Nyxoah's higher probable upside, research analysts clearly believe Nyxoah is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals hold more shares of NYXH or PLSE? 77.0% of Pulse Biosciences shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by company insiders. Comparatively, 71.5% of Pulse Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, NYXH or PLSE? Nyxoah has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500. Comparatively, Pulse Biosciences has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500. Does the media refer more to NYXH or PLSE? In the previous week, Pulse Biosciences had 3 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for Pulse Biosciences and 0 mentions for Nyxoah. Pulse Biosciences' average media sentiment score of 0.50 beat Nyxoah's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Nyxoah Neutral Pulse Biosciences Positive SummaryPulse Biosciences beats Nyxoah on 7 of the 13 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition Export to ExcelMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$254.09M$2.02B$5.57B$9.48BDividend YieldN/AN/A4.31%4.14%P/E Ratio-3.4034.4629.3423.98Price / Sales50.509.98442.0695.84Price / CashN/A50.6235.8458.51Price / Book2.018.718.085.58Net Income-$64.10M-$63.67M$3.26B$265.35M7 Day Performance1.83%-2.71%-0.73%-0.89%1 Month Performance-6.69%8.60%5.52%4.98%1 Year Performance-5.35%21.33%28.79%23.50% Nyxoah Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah2.5784 of 5 stars$7.25-2.8%$14.50+100.0%-6.4%$254.09M$4.89M-3.40110Positive NewsPLSEPulse Biosciences3.8777 of 5 stars$15.21+1.9%$22.00+44.6%+8.9%$1.00B$700K0.00140Upcoming EarningsMDXGMiMedx Group2.6428 of 5 stars$6.79+0.3%$11.50+69.4%+11.5%$999.94M$348.88M25.15870Earnings ReportINMDInMode3.1495 of 5 stars$14.54-1.2%$18.54+27.5%-14.3%$930.44M$394.82M6.24480Earnings ReportKMTSKestra Medical Technologies1.5495 of 5 stars$16.50-0.3%$27.33+65.7%N/A$849.82M$59.81M0.00300Positive NewsSIBNSiBone4.1556 of 5 stars$17.60+2.0%$22.50+27.8%+14.0%$735.10M$167.18M-27.50350News CoveragePositive NewsEarnings ReportAnalyst ForecastIRMDiRadimed4.0811 of 5 stars$57.11+1.4%$72.00+26.1%+57.2%$716.11M$73.24M36.85110News CoverageDividend AnnouncementGap DownEMBCEmbecta4.736 of 5 stars$11.33-3.4%$19.00+67.7%-29.8%$685.53M$1.12B12.592,100News CoveragePositive NewsUpcoming EarningsBBNXBeta Bionics2.6889 of 5 stars$13.99-5.7%$23.44+67.6%N/A$643.41M$65.12M0.00294AXGNAxoGen2.2907 of 5 stars$12.99-2.8%$24.50+88.6%+76.0%$608.92M$187.34M-86.59450News CoverageHigh Trading VolumeAVNSAvanos Medical1.7294 of 5 stars$12.02+0.1%N/A-56.5%$555.39M$687.80M-1.442,227Trending NewsEarnings Report Related Companies and Tools Related Companies Pulse Biosciences Competitors MiMedx Group Competitors InMode Competitors Kestra Medical Technologies Competitors SiBone Competitors iRadimed Competitors Embecta Competitors Beta Bionics Competitors AxoGen Competitors Avanos Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NYXH Stock Alerts